The IBA uses cookies to provide you with a better website experience. By continuing to use our site, you are agreeing to the use of cookies.
Manage cookies

Tag results for 'FCPA'

Changes in the US DoJ’s corporate enforcement policy: implications for Indian companies

This article analyses possible implications of changes to the US Department of Justice’s enforcement policy for Indian companies.

Released on Apr 25, 2022

Disclosure of an Indian issuer’s potential FCPA violations: the implications for other Indian companies

Dr Reddy’s Laboratories Ltd (Dr Reddy’s), a large Indian pharmaceutical company, has American Depositary Receipts (ADRs) listed on the New York Stock Exchange and is an ‘issuer’ under the Foreign Corrupt Practices Act, 1977 (FCPA). In November 2020, Dr Reddy’s made a filing before the US Securities and Exchange Commission (SEC) stating that it had begun an investigation into an anonymous complaint alleging breaches of anti-corruption laws, specifically the FCPA.

Released on Oct 29, 2021

International Bar Association 2024 © Privacy policy Terms & conditions Cookie policy Harassment policy

International Bar Association is incorporated as a Not-for-Profit Corporation under the laws of the State of New York in the United States of America and is registered with the Department of State of the State of New York with registration number 071114000655 - and the liability of its members is limited. Its registered address in New York is c/o Capitol Services Inc, 1218 Central Avenue, Suite 100, Albany, New York 12205.

The London office of International Bar Association is registered in England and Wales as a branch with registration number FC028342.